Circulating Tumor Cells: A Multifunctional Biomarker

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Cancer Research

• Publication date

  2014-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-13-2664PMID 24831278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.

  2014cited by this paper
• Universal marker and detection tool for human sarcoma circulating tumor cells.

  2014cited by this paper
• Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.

  2014cited by this paper
• Genome-Wide Association Study: A Useful Tool to Identify Common Genetic Variants Associated with Drug Toxicity and Efficacy in Cancer Pharmacogenomics

  2014cited by this paper
• Technologies for detection of circulating tumor cells: facts and vision.

  2014cited by this paper
• Pharmacologic Biomarkers in the Development of Stratified Cancer Medicine

  2014cited by this paper
• Pharmacodynamic Biomarkers: Falling Short of the Mark?

  2014cited by this paper
• In Vivo Imaging as a Pharmacodynamic Marker

  2014cited by this paper
• Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platform.

  2014cited by this paper
• Using Pharmacogene Polymorphism Panels to Detect Germline Pharmacodynamic Markers in Oncology

  2014cited by this paper
• Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer

  2013cited by this paper
• Real-time liquid biopsy in cancer patients: fact or fiction?

  2013cited by this paper
• Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer

  2013cited by this paper
• Detection of cancer before distant metastasis

  2013cited by this paper
• Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay.

  2013cited by this paper
• Metastasis Awakening: The challenges of targeting minimal residual cancer

  2013cited by this paper
• Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

  2013cited by this paper
• Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer

  2013cited by this paper
• Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

  2013cited by this paper
• Biologic challenges in the detection of circulating tumor cells.

  2013cited by this paper
• Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

  2013cited by this paper
• Cytokeratin-based CTC counting unrelated to clinical follow up.

  2013cited by this paper
• Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis

  2013cited by this paper
• Enrichment, detection and clinical significance of circulating tumor cells.

  2013cited by this paper
• A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases

  2013cited by this paper
• Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells

  2013cited by this paper
• Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

  2013cited by this paper
• Analysis of Circulating Tumor Cells in Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy

  2013cited by this paper
• Abstract 1472: Assessment of CTC-based pharmacodynamic biomarkers in NCI clinical trials of targeted anticancer therapeutics.

  2013cited by this paper
• Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip.

  2013cited by this paper
• Intratumor Heterogeneity: Seeing the Wood for the Trees

  2012cited by this paper
• Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

  2012cited by this paper
• Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

  2012cited by this paper
• Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers

  2012cited by this paper
• Abstract 2395: HER-2 FISH analysis and H & E staining of circulating tumor cells pre-isolated using high porosity precision microfilters

  2012cited by this paper
• Molecular assays for the detection and characterization of CTCs.

  2012cited by this paper
• mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer

  2012cited by this paper
• Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

  2012cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper
• Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.

  2012cited by this paper
• A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire

  2012cited by this paper
• Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.

  2012cited by this paper
• Considerations in the development of circulating tumor cell technology for clinical use

  2012cited by this paper
• ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood.

  2012cited by this paper
• EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.

  2012cited by this paper
• Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

  2012cited by this paper
• A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.

  2012influential reference
• A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients

  2011cited by this paper
• External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

  2011cited by this paper
• Circulating melanoma cells and survival in metastatic melanoma.

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• Utilizing circulating tumor cells: challenges and pitfalls.

  2011cited by this paper
• Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device.

  2011cited by this paper
• Final results of a translational phase l study assessing a QOD schedule of the potent AKT inhibitor MK-2206 incorporating predictive, pharmacodynamic (PD), and functional imaging biomarkers.

  2011cited by this paper
• Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.

  2011cited by this paper
• Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials.

  2011cited by this paper
• Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology

  2011cited by this paper
• Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival

  2011cited by this paper
• Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy

  2011cited by this paper
• Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

  2011cited by this paper
• A new device for rapid isolation by size and characterization of rare circulating tumor cells.

  2011cited by this paper
• Circulating tumor cells: will they be clinically useful?

  2010cited by this paper
• Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

  2010cited by this paper
• Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

  2010cited by this paper
• Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

  2010cited by this paper
• Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer

  2010cited by this paper
• Envisioning the future of early anticancer drug development

  2010influential reference
• HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

  2010influential reference
• Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate.

  2010cited by this paper
• Circulating tumour cells: their utility in cancer management and predicting outcomes

  2010cited by this paper
• Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

  2010cited by this paper
• Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells

  2010cited by this paper
• Molecular Biomarker Analyses Using Circulating Tumor Cells

  2010cited by this paper
• Gene expression profiling of peripheral blood cells for early detection of breast cancer

  2010cited by this paper
• Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

  2010cited by this paper
• Microdevice for the isolation and enumeration of cancer cells from blood

  2009cited by this paper
• A simple biological imaging system for detecting viable human circulating tumor cells.

  2009cited by this paper
• Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.

  2009cited by this paper
• Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.

  2009cited by this paper
• Characterization of circulating tumor cells by fluorescence in situ hybridization

  2009cited by this paper
• Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.

  2009cited by this paper
• Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

  2009cited by this paper
• Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells

  2009cited by this paper
• Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.

  2009cited by this paper
• Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

  2009cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

  2008cited by this paper
• Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells

  2008cited by this paper
• Detection of mutations in EGFR in circulating lung-cancer cells.

  2008influential reference
• Statistical considerations for enumeration of circulating tumor cells

  2007cited by this paper
• Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor

  2007cited by this paper
• Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Case study of the morphologic variation of circulating tumor cells.

  2007cited by this paper
• Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.

  2006influential reference
• Circulating tumor cells: the 'leukemic phase' of solid cancers.

  2006cited by this paper
• HER-2 gene amplification can be acquired as breast cancer progresses.

  2004cited by this paper
• Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.

  2004cited by this paper

• Liquid biopsy for the management of gastrointestinal cancers.

  2025cites this paper
• Circulating tumor cells as key biomarkers for risk assessment and diagnosis of malignant salivary gland tumors

  2025cites this paper
• Cadherin-1-mediated communication at the leader-follower boundary controls mouse breast tumor organoid collective migration

  2025cites this paper
• Liquid biopsy for the diagnosis, prognosis, and monitoring of common cancers: global and Brazilian perspectives

  2025cites this paper
• High-throughput atomic force microscopy measurements reveal mechanical signatures of cell mixtures for liquid biopsy.

  2025cites this paper
• Functional biomaterials and machine learning approaches for phenotyping heterogeneous tumor cells and extracellular vesicles.

  2025cites this paper
• PADI4 expression in baseline circulating tumour cells acts as a prognostic biomarker in oral squamous cell carcinoma

  2025cites this paper
• Harnessing technologies to unravel gastric cancer heterogeneity.

  2025cites this paper
• Liquid biopsy: An innovative tool in oncology. Where do we stand?

  2025cites this paper
• Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection

  2024cites this paper
• Recent Advancements of Nanomedicine in Breast Cancer Surgery

  2024cites this paper
• Exosomal ncRNAs in liquid biopsies for lung cancer.

  2024cites this paper
• ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA

  2024cites this paper
• Tumor-immune hybrid cells evade the immune response and potentiate colorectal cancer metastasis through CTLA4

  2024cites this paper
• TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs

  2024cites this paper
• A panorama of colon cancer in the era of liquid biopsy

  2024cites this paper
• A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma

  2024cites this paper
• Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm

  2023cites this paper
• Liquid biopsy in ovarian cancer in China and the world: current status and future perspectives

  2023cites this paper
• Challenges and future of HER2-positive gastric cancer therapy

  2023cites this paper
• Micro-Magnetofluidic System for Rare Cell Analysis: From Principle to Translation

  2023cites this paper
• Application of Circulating Tumor Cells and Interleukin-6 in Preoperative Prediction of Peritoneal Metastasis of Advanced Gastric Cancer

  2023cites this paper
• μDACS platform: A hybrid microfluidic platform using magnetic levitation technique and integrating magnetic, gravitational, and drag forces for density-based rare cancer cell sorting

  2023cites this paper
• USP9X expression is functionally related to laryngeal cancer

  2023influential citation
• Development of Metal-Organic Framework-Based Dual Antibody Nanoparticles for the Highly Specific Capture and Gradual Release of Circulating Tumor Cells

  2022cites this paper
• Detection of rare CTCs by electrochemical biosensor built on quaternary PdPtCuRu nanospheres with mesoporous architectures.

  2022cites this paper
• Label‐free enrichment of MCF7 breast cancer cells from leukocytes using continuous flow dielectrophoresis

  2022cites this paper
• A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence

  2022cites this paper
• Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications

  2022cites this paper
• Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer

  2022cites this paper
• Advances in Microfluidics for the Implementation of Liquid Biopsy in Clinical Routine.

  2022cites this paper
• Microfluidic flow cytometry for blood-based biomarker analysis.

  2022cites this paper
• A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?

  2022cites this paper
• Circulating tumor cells as a "real-time liquid biopsy": Recent advances and the application in ovarian cancer.

  2022cites this paper
• Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem

  2022cites this paper
• An intravascular needle coated by ZnO nanoflowers for in vivo elimination of circulating tumor cells

  2022cites this paper
• Detection of circulating tumour cells in colorectal cancer: Emerging techniques and clinical implications

  2021cites this paper
• Specific study of biological tumor cytology: a narrative review

  2021cites this paper
• Proteomics and its applications in breast cancer.

  2021cites this paper
• Herringbone Microfluidic Probe for Multiplexed Affinity‐Capture of Prostate Circulating Tumor Cells

  2021cites this paper
• A Novel Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells

  2021cites this paper
• Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

  2021cites this paper
• Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device

  2021cites this paper
• Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development

  2021cites this paper
• Molecular pathology underlying the robustness of cancer stem cells

  2021cites this paper
• A double-tetrahedral DNA framework based electrochemical biosensor for ultrasensitive detection and release of circulating tumor cells.

  2021cites this paper
• An Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells

  2021cites this paper
• System Modularity Chip for Analysis of Rare Targets (SMART-Chip): Liquid Biopsy Samples.

  2021cites this paper
• In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer

  2021cites this paper
• Capture-free deactivation of CTCs in the bloodstream; a metastasis suppression method by electrostatic stimulation of the peripheral blood.

  2021cites this paper
• Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer

  2020cites this paper
• Revisiting the Roles of Pro-Metastatic EpCAM in Cancer

  2020cites this paper
• Development of Pharmacodynamic Biomarkers for Phase I Trials

  2020cites this paper
• Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells

  2020cites this paper
• Phase I Oncology Drug Development

  2020influential citation
• Circulating biomarkers in malignant pleural mesothelioma

  2020cites this paper
• A Novel Microfluidic Method Utilizing a Hydrofoil Structure to Improve Circulating Tumor Cell Enrichment: Design and Analytical Validation

  2020cites this paper
• Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX®‐i120 Platform: A prospective study

  2020cites this paper
• Evaluating the Potential for Circulating Tumor Cells as a Diagnostic and Prognostic Biomarker in Various Cancer Types

  2020cites this paper
• Drug transporters in the development of multidrug resistance in colorectal cancer

  2020cites this paper
• Biodetection and sensing for cancer diagnostics

  2020cites this paper
• Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy

  2020cites this paper
• A single‐view field filter device for rare tumor cell filtration and enumeration

  2020cites this paper
• Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells

  2020cites this paper
• Circulating Tumor Cells in Breast Cancer Metastatic Disease

  2020cites this paper
• Epigenetics of Circulating Tumor Cells in Breast Cancer.

  2020cites this paper
• ctDNA Detection in Microfluidic Platform: A Promising Biomarker for Personalized Cancer Chemotherapy

  2020cites this paper
• Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion.

  2020cites this paper
• Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients

  2020cites this paper
• Utilidad clínica de la biopsia líquida para el diagnóstico y seguimiento de los pacientes con CPNM y EML4-ALK

  2020cites this paper
• Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer

  2020cites this paper
• A smart procedure for the femtosecond laser-based fabrication of a polymeric lab-on-a-chip for capturing tumor cell

  2020cites this paper
• A microfluidic system based on the monoclonal antibody BCMab1 specifically captures circulating tumor cells from bladder cancer patients

  2020cites this paper
• 53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

  2020cites this paper
• Emerging Role of Circulating Tumor Cells in Gastric Cancer

  2020cites this paper
• Tumorspheres as an in vitro model for cancer stem-like cell characterization in non-small cell lung cancer. Prognostic implications

  2020cites this paper
• An electrochemical signal-on apta-cyto-sensor for quantitation of circulating human MDA-MB-231 breast cancer cells by transduction of electro-deposited non-spherical nanoparticles of gold.

  2019cites this paper
• Plug-and-Play In Vitro Metastasis System toward Recapitulating the Metastatic Cascade

  2019cites this paper
• Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies

  2019cites this paper
• Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities.

  2019cites this paper
• Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma

  2019cites this paper
• Tumour biomarkers—Tracing the molecular function and clinical implication

  2019cites this paper
• A two-dimensional immunomagnetic nano-net for the efficient isolation of circulating tumor cells in whole blood.

  2019cites this paper
• Hybrid negative enrichment of circulating tumor cells from whole blood in a 3D-printed monolithic device.

  2019cites this paper
• Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients

  2019cites this paper
• Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications

  2019cites this paper
• Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.

  2019cites this paper
• Research landscape of liquid biopsies in prostate cancer.

  2019cites this paper
• Identification and Characterization of Circulating Tumor Cells in Men Who Have Undergone Prostatectomy for Clinically Localized, High - Risk Prostate Cancer.

  2019cites this paper
• Circulating Tumor Cells: High-Throughput Imaging of CTCs and Bioinformatic Analysis.

  2019cites this paper
• Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization

  2019cites this paper
• Liquid biopsy challenge and hope in colorectal cancer

  2019cites this paper
• Recent advances in microfluidic methods in cancer liquid biopsy.

  2019cites this paper
• Metode za izolaciju cirkulirajućih tumorskih stanica

  2019cites this paper
• Integrated Microfluidic Chip for Efficient Isolation and Deformability Analysis of Circulating Tumor Cells

  2018cites this paper
• Precision Molecular Pathology of Liver Cancer

  2018cites this paper
• Integrating Electrochemical Immunosensing and Cell Adhesion Technologies for Cancer Cell Detection and Enumeration.

  2018cites this paper
• Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach

  2018cites this paper
• RhoA‐stimulated intra‐capillary morphology switch facilitates the arrest of individual circulating tumor cells

  2018cites this paper
• Identification of mechanisms of acquired resistance to taxanes in triple negative breast cancer using patient-derived xenografts: a step closer to clinics

  2018cites this paper